We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
Cap. Flow
+$1.13B
Cap. Flow %
11.96%
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$51.9M
2
MRK icon
Merck
MRK
+$50.9M
3
DHR icon
Danaher
DHR
+$45.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$37.8M
5
JD icon
JD.com
JD
+$37.7M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$103M
2
BABA icon
Alibaba
BABA
+$98.6M
3
CRM icon
Salesforce
CRM
+$62.5M
4
BMY icon
Bristol-Myers Squibb
BMY
+$59.4M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.61%
2 Technology 20.94%
3 Consumer Discretionary 8.9%
4 Financials 8.59%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FDX icon
401
FedEx
FDX
$73B
$3.08M 0.03%
21,940
-8,055
-27% -$1.01M
INFY icon
402
Infosys
INFY
$51B
$3.07M 0.03%
318,207
-78,525
-20% -$701K
SLG icon
403
SL Green Realty
SLG
$3.83B
$3.07M 0.03%
64,273
+45,389
+240% +$2.08M
FPRX
404
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$3.06M 0.03%
502,177
+502,171
+8,369,517% +$2.07M
ROST icon
405
Ross Stores
ROST
$80.8B
$3.02M 0.03%
22,783
-17,081
-43% -$1.55M
IBN icon
406
ICICI Bank
IBN
$107B
$3.02M 0.03%
324,552
-14,625
-4% -$130K
EWC icon
407
iShares MSCI Canada ETF
EWC
$6.12B
$2.99M 0.03%
115,591
-38,270
-25% -$936K
LNC icon
408
Lincoln National
LNC
$7.92B
$2.97M 0.03%
80,678
-89,366
-53% -$3.15M
TMUS icon
409
T-Mobile US
TMUS
$195B
$2.94M 0.03%
28,228
-12,858
-31% -$1.23M
ALLO icon
410
Allogene Therapeutics
ALLO
$625M
$2.91M 0.03%
+67,927
New +$2.46M
AVTR icon
411
Avantor
AVTR
$9.82B
$2.91M 0.03%
171,000
– –
AZN icon
412
AstraZeneca
AZN
$269B
$2.89M 0.03%
27,343
-22,697
-45% -$2.34M
APLT
413
DELISTED
Applied Therapeutics
APLT
$2.89M 0.03%
+80,000
New +$3.35M
BSX icon
414
Boston Scientific
BSX
$68.4B
$2.85M 0.03%
81,267
-20,286
-20% -$731K
FFIV icon
415
F5
FFIV
$22B
$2.85M 0.03%
20,457
+2,706
+15% +$364K
TDOC icon
416
Teladoc Health
TDOC
$1.66B
$2.83M 0.03%
+9,042
New +$1.58M
TTWO icon
417
Take-Two Interactive
TTWO
$46.1B
$2.81M 0.03%
20,145
-49,424
-71% -$6.46M
PCAR icon
418
PACCAR
PCAR
$70.5B
$2.78M 0.03%
55,778
-219,420
-80% -$10.3M
DOW icon
419
Dow Inc
DOW
$22B
$2.77M 0.03%
67,950
-13,752
-17% -$503K
UHS icon
420
Universal Health Services
UHS
$10.2B
$2.75M 0.03%
29,601
-3,318
-10% -$332K
BCE icon
421
BCE
BCE
$20.8B
$2.74M 0.03%
66,006
+10,022
+18% +$413K
WBA
422
DELISTED
Walgreens Boots Alliance
WBA
$2.74M 0.03%
64,688
-33
-0.1% -$1.4K
TU icon
423
Telus
TU
$17.4B
$2.71M 0.03%
162,397
+72,248
+80% +$1.2M
GM icon
424
General Motors
GM
$80.9B
$2.68M 0.03%
105,833
-151,054
-59% -$3.67M
KEY icon
425
KeyCorp
KEY
$23.8B
$2.63M 0.03%
215,969
-30,922
-13% -$359K
15 16
17
18 19

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2020 Portfolio in Review

As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.

  • Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
  • Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
  • Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
  • Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
  • Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.